Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Outlook 2031
- The global chronic obstructive pulmonary disease (COPD) treatment market was valued at US$ 19.8 Bn in 2021
- The global market is projected to grow at a CAGR of 4.4% from 2022 to 2031
- The global chronic obstructive pulmonary disease (COPD) treatment market is anticipated to reach more than US$ 30.4 Bn by the end of 2031
Analysts’ Viewpoint on Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Scenario
Exposure to tobacco smoke (which includes secondhand or passive smoking), allergens (such as pollen, ragweed, dust mites, or animal dander), irritants in the air (such as chemical fumes, smoke, or strong odors), and extreme weather conditions are risk factors that are responsible for driving the global chronic obstructive pulmonary disease treatment market. Other risk factors such as indoor air pollution (such as solid fuel used for heating and cooking), outdoor air pollution, occupational dusts and chemicals (such as irritants, vapors, and fumes), and frequent lower respiratory infections during childhood are also augmenting the global chronic obstructive pulmonary disease treatment market. Companies operating in the global market are focusing on introducing innovative and technologically advanced products to create lucrative revenue streams. Rise in adoption of digital inhalers and triple therapy treatment options is expected to create incremental opportunities for manufacturers in the COPD treatment market during the forecast period.
Overview of Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
Chronic obstructive pulmonary disease is a group of conditions affecting lungs that leads to difficulty in breathing. Chronic bronchitis and emphysema are two major types of COPD. Breathlessness is a major characteristic of COPD. In case of emphysema, the alveoli (tiny air sacs) in the lungs are damaged. The walls of the alveoli are stretched, making the lungs bigger. This results in difficulty in the movement of air. In chronic bronchitis, bronchial airways (breathing tubes) inside the lungs are inflamed.
High prevalence of COPD across the globe and rich pipeline of drugs for COPD treatment are likely to drive the global market during the forecast period. Increase in geriatric population and rise in unhealthy lifestyle among various age groups are also projected to propel the chronic obstructive pulmonary disease (COPD) treatment market in the near future.
Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73763
Rise in Tobacco Smoking to Propel Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
Chronic obstructive pulmonary disease (COPD) is a major health concern affecting a large number of people across the globe. The disease burden is rising, thereby increasing the need for COPD management.
Tobacco smoking could lead to COPD. The number of adults addicted to smoking has been increasing across the globe. Other risk factors include occupation and indoor air pollution. According to the WHO, the primary cause of COPD is exposure to tobacco smoke (either active or passive smoking).
According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally, accounting for 3.23 million deaths in 2019. Nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries (LMIC).
According to a report by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) published in 2022, the prevalence and burden of COPD are projected to increase in the near future due to continued exposure to COPD risk factors and aging of population across the globe. This is anticipated to augment the chronic obstructive pulmonary disease treatment market in the near future.
Increase in Adoption of Combination Therapy to Drive Market
Combination therapy includes LAMA-ICS, LABA-ICS, triple therapy, and other combination drugs. Adoption of combination therapy is increasing, as it is more effective than the separate use of bronchodilator and corticosteroid. Increase in number of patients being successfully treated with combination therapy, who were not showing signs of recovery with bronchodilators or corticosteroids treatments, is expected to boost the global chronic obstructive pulmonary disease treatment market. Combination therapy is more effective than monotherapy for improving chronic obstructive pulmonary disease symptoms and quality of life.
Growth in Success Rate of COPD Treatment and Recent Regulatory Approvals to Augment Combination Therapy Segment
In terms of drug class, the combination therapy segment held major share of around 50% of the global market in 2021. It is likely to dominate the global market during the forecast period, owing to the increase in efficacy of combination therapy in COPD treatment.
Rise in success rate of combination therapy in COPD treatment and recent regulatory approvals have augmented the adoption of combination therapy. This is projected to drive the segment during the forecast period.
Rise in Number of COPD Therapeutics Dispensed to Boost Retail Pharmacies Segment
Based on distribution channel, the retail pharmacies segment is anticipated to account for major share of the global chronic obstructive pulmonary disease treatment market during the forecast period.
The segment is expected to grow at a rapid pace during the forecast period, owing to the increase in number of COPD therapeutics dispensed through retail pharmacies and rise in number of retail pharmacies in developing countries.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=73763
About Transparency Market Research
Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End-Use that will favor growth in the market over the next 9 years.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
Fact.MR has recently published a new research that provides detailed insights on the working dynamics of the global Cancer Profiling market.
The research report offers in-depth information about the key market segments, vendor landscape, geographical outlook, and the factors driving and inhibiting growth.According to the research report, the global market for Cancer Profiling is currently expanding a healthy CAGR of 4.7% over the course of the given period of forecast ranging from 2018 to 2028.
According to the report, the cancer profiling market is projected to grow at 4.7% CAGR through 2028.Request to View Sample of Research Report @ https://www.factmr.com/connectus/sample?flag=S_id=358The research report offers a detailed insight on the profiles of the key companies operating in the global Cancer Profiling market.
The companies included in the report areIllumina IncQIAGENThermo Fisher Scientific IncAbbottNanostring Technologies IncSiemens AGHTG Molecular Diagnostics, IncThe Cancer Profiling market report offers assessment of prevailing opportunities in various regions and evaluates their shares of revenue by the end of different years of the assessment period.
Key regions covered comprise:North AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaThe research report provides in depth information about the current condition of the competitive landscape of the global Cancer Profiling market.
Moreover, it also provides information the different factors that has shaped the marketing strategies of the key players operating in the global market.
Biomaterials Market Analysis 2021 covers the global and regional market with an in-depth analysis of the overall growth prospects in the market.
The Biomaterials Market size was valued at US$ 120.0 Bn in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 15.1% for the forecast period ending 2027 reaching a Market value of US$ 320.2 Bn.
The study also involves the important Achievements of the market, Research & Development, new product launch, product responses, and regional growth of the most important competitors operating in the market on a universal and local scale.Key Attributes of Market Report:The ongoing status of global Biomaterials market current market updates and regional levelsUnderstanding of global marketplace developmentA study of this market-attracted place on product salesCompetitive analysis is specified for eminent players like BASF SE, Zimmer Biomet Holdings Inc, Corbion NV, Bayer AG, Carpenter Technology Corporation, and more, price structures, and value of production.Various stakeholders in this industry, including research and consulting firms, investors for new entrants, and financial analysts, product manufacturers, distributors, and suppliers are listed.Top players Covered in Biomaterials Market Study are:BASF SEZimmer Biomet Holdings IncCorbion NVBayer AGCarpenter Technology CorporationVictrex PLCNoble Biomaterials IncDentsply InternationalRoyal DSMBerkeley Advanced Biomaterials IncEvonik Industries AGMedtronic plc and Invibio Ltd.Biomaterials Market SegmentationBiomaterials market is split by Type and by Application.
For the period 2020-2027, the growth among segments provides accurate calculations and forecasts for sales by Type and by Application in terms of volume and value.
This analysis can help you expand your business by targeting qualified niche markets.Market Segmentation by Type:By Type(Natural Biomaterials, Ceramic Biomaterials, Metallic Biomaterials, Polymeric Biomaterials)Market Segmentation by Applications:By Application(Neurology, Orthopaedic, Cardiology, Wound Care, Ophthalmology, Tissue Care, Dental, Plastic Surgery, Others)Regions covered in Biomaterials Market report:North America (U.S. and Canada)Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe)Asia Pacific (China, Japan, India, Indonesia, and Rest of Asia Pacific)Latin America (Brazil, Mexico, and Rest of Latin America)Middle East & Africa (GCC, South Africa and Rest of Middle East & Africa)Drivers and Risks Analysis in Biomaterials Market:The global Biomaterials market is characterized by several leading factors, with each factor playing a crucial role in the growth of the industry.
The growing demand for products coupled with easy availability of the same has helped the industry flourish across the globe.Research Methodology: Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made.
